Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors influencing cancer genetic somatic mutation test ordering by cancer physician.

Journal of translational medicine - 12 Nov 2020

Demeshko Anastassia, Pennisi David J, Narayan Sushil, Gray Stacy W, Brown Matthew A, McInerney-Leo Aideen M

Abstract excerpt

BACKGROUND: Clinical whole exome sequencing was introduced in an Australian centre in 2017, as an alternative to Sanger sequencing. We aimed to identify predictors of cancer physicians' somatic mutation test ordering behaviour. METHODS: A validated instrument assessed somatic mutation test ordering, genomic confidence, perceived utility of tumour molecular profiling, and percent of patients eligible for targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Mutation

Share to Neoplasms

Share to Physicians

Source

Open in PubMed Open full text

Identifiers

PMID: 33183308
DOI: 10.1186/s12967-020-02610-7
PMCID: PMC7663861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors influencing cancer genetic somatic mutation test ordering by cancer physician.PMID 33183308Read ↗

Factors Influencing Cancer Genetic Somatic Mutation Test Ordering By Cancer PhysiciansSemantic proximity Read ↗

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.Semantic proximity Read ↗

Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK.Semantic proximity Read ↗

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read ↗

Impact of genetic counselling strategy on diagnostic yield and workload for genome sequencing-based tumour diagnosticsSemantic proximity Read ↗

Experiences Accessing and Receiving Tumour Genetic Profiling in Victoria: A Consumer-Led Cross-Sectional Survey StudySemantic proximity Read ↗

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.Semantic proximity Read ↗

Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories.Semantic proximity Read ↗

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologistsSemantic proximity Read ↗

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian surveySemantic proximity Read ↗

Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor TestingSemantic proximity Read ↗

Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in PracticeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.